TOXICITY ASSOCIATED WITH GENE POLYMORPHISMS IN PATIENTS WITH COLORECTAL CANCER, TREATED WITH FLUOROPYRIMIDINES AND ANALOGUES, IRINOTECAN AND PLATINUM COORDINATION COMPLEXES